Literature DB >> 30692598

WNT1-associated osteogenesis imperfecta with atrophic frontal lobes and arachnoid cysts.

Piranit Nik Kantaputra1,2, Yuddhasert Sirirungruangsarn3, Pannee Visrutaratna4, Sasitorn Petcharunpaisan5, Bruce M Carlson6, Worrachet Intachai7, Jutamas Sudasna8, Jatupol Kampuansai9, Prapai Dejkhamron8.   

Abstract

A rare form of osteogenesis imperfecta (OI) caused by Wingless-type MMTV integration site family 1 (WNT1) mutations combines central nervous system (CNS) anomalies with the characteristic increased susceptibility to fractures. We report an additional case where arachnoid cysts extend the phenotype, and that also confirms the association of intellectual disabilities with asymmetric cerebellar hypoplasia here. Interestingly, if the cerebellum is normal in this disorder, intelligence is as well, analogous to an association with similar delays in a subset of patients with sporadic unilateral cerebellar hypoplasia. Those cases typically appear to represent vascular disruptions, and we suggest that most brain anomalies in WNT1-associated OI have vascular origins related to a role for WNT1 in CNS angiogenesis. This unusual combination of benign cerebellar findings with effects on higher functions in these two situations raises the possibility that WNT1 is involved in the pathogenesis of the associated sporadic cases as well. Finally, our patient reacted poorly to pamidronate, which appears ineffective with this form of OI, so that a lack of improvement is an indication for molecular testing that includes WNT1.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30692598     DOI: 10.1038/s10038-019-0565-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

1.  Genetic subdivision of the tectum and cerebellum into functionally related regions based on differential sensitivity to engrailed proteins.

Authors:  Sema K Sgaier; Zhimin Lao; Melissa P Villanueva; Frada Berenshteyn; Daniel Stephen; Rowena K Turnbull; Alexandra L Joyner
Journal:  Development       Date:  2007-06       Impact factor: 6.868

2.  Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis.

Authors:  Richard Daneman; Dritan Agalliu; Lu Zhou; Frank Kuhnert; Calvin J Kuo; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

3.  Mutations in WNT1 are a cause of osteogenesis imperfecta.

Authors:  Somayyeh Fahiminiya; Jacek Majewski; John Mort; Pierre Moffatt; Francis H Glorieux; Frank Rauch
Journal:  J Med Genet       Date:  2013-02-23       Impact factor: 6.318

4.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

5.  Unilateral cerebellar hypoplasia with different clinical features.

Authors:  Gulcin Benbir; Simay Kara; Beyza Citci Yalcinkaya; Geysu Karhkaya; Beyhan Tuysuz; Naci Kocer; Cengiz Yalcinkaya
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

6.  Cystic malformation of the posterior cerebellar vermis in transgenic mice that ectopically express Engrailed-1, a homeodomain transcription factor.

Authors:  D H Rowitch; P S Danielian; A P McMahon; N Zec
Journal:  Teratology       Date:  1999-07

7.  WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.

Authors:  Shawna M Pyott; Thao T Tran; Dru F Leistritz; Melanie G Pepin; Nancy J Mendelsohn; Renee T Temme; Bridget A Fernandez; Solaf M Elsayed; Ezzat Elsobky; Ishwar Verma; Sreelata Nair; Emily H Turner; Joshua D Smith; Gail P Jarvik; Peter H Byers
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

8.  Mutations in WNT1 cause different forms of bone fragility.

Authors:  Katharina Keupp; Filippo Beleggia; Hülya Kayserili; Aileen M Barnes; Magdalena Steiner; Oliver Semler; Björn Fischer; Gökhan Yigit; Claudia Y Janda; Jutta Becker; Stefan Breer; Umut Altunoglu; Johannes Grünhagen; Peter Krawitz; Jochen Hecht; Thorsten Schinke; Elena Makareeva; Ekkehart Lausch; Tufan Cankaya; José A Caparrós-Martín; Pablo Lapunzina; Samia Temtamy; Mona Aglan; Bernhard Zabel; Peer Eysel; Friederike Koerber; Sergey Leikin; K Christopher Garcia; Christian Netzer; Eckhard Schönau; Victor L Ruiz-Perez; Stefan Mundlos; Michael Amling; Uwe Kornak; Joan Marini; Bernd Wollnik
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

9.  The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum.

Authors:  A P McMahon; A L Joyner; A Bradley; J A McMahon
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

10.  Swaying is a mutant allele of the proto-oncogene Wnt-1.

Authors:  K R Thomas; T S Musci; P E Neumann; M R Capecchi
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

View more
  3 in total

Review 1.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

Review 2.  The Regulation of Bone Metabolism and Disorders by Wnt Signaling.

Authors:  Kazuhiro Maeda; Yasuhiro Kobayashi; Masanori Koide; Shunsuke Uehara; Masanori Okamoto; Akihiro Ishihara; Tomohiro Kayama; Mitsuru Saito; Keishi Marumo
Journal:  Int J Mol Sci       Date:  2019-11-06       Impact factor: 5.923

3.  Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the WNT1 gene.

Authors:  Maria Cristina Campopiano; Antonella Fogli; Angela Michelucci; Laura Mazoni; Antonella Longo; Simona Borsari; Elena Pardi; Elena Benelli; Chiara Sardella; Laura Pierotti; Elisa Dinoi; Claudio Marcocci; Filomena Cetani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.